Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ironwood Pharmaceuticals, Inc. - Class A Common Stock (NQ:IRWD)

1.340 -0.020 (-1.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,832,064
Open 1.290
Bid (Size) 1.260 (25)
Ask (Size) 1.520 (1)
Prev. Close 1.360
Today's Range 1.250 - 1.360
52wk Range 1.250 - 8.450
Shares Outstanding 160,028,388
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
From Ironwood Pharmaceuticals, Inc.
Via Business Wire

Performance

YTD
-69.1%
-69.1%
1 Month
-13.0%
-13.0%
3 Month
-70.3%
-70.3%
6 Month
-68.8%
-68.8%
1 Year
-83.6%
-83.6%

More News

Read More
Earnings Scheduled For February 27, 2025
Via Benzinga
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Earnings Preview: Ironwood Pharmaceuticals
Via Benzinga
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
Top stock movements in today's session.
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Wednesday?
Via Chartmill
Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
Via Benzinga
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is Ironwood Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Ironwood Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Ironwood Pharmaceuticals, Inc. - Class A Common Stock trade on?
Ironwood Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ironwood Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Ironwood Pharmaceuticals, Inc. - Class A Common Stock is IRWD on the Nasdaq Stock Market
What is the current price of Ironwood Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Ironwood Pharmaceuticals, Inc. - Class A Common Stock is 1.340
When was Ironwood Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Ironwood Pharmaceuticals, Inc. - Class A Common Stock was at 04/04/25 04:00 PM ET
What is the market capitalization of Ironwood Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Ironwood Pharmaceuticals, Inc. - Class A Common Stock is 214.44M
How many shares of Ironwood Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Ironwood Pharmaceuticals, Inc. - Class A Common Stock has 214M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.